What the HHT?
A blog for the HHT community
FDA Adds Boxed Warning to Ferric Carboxymaltose Following Petition Led by Cure HHT’s Dr. Scott Olitsky
The FDA has granted a citizen petition led by Cure HHT’s Dr. Scott Olitsky, adding a boxed warning to ferric carboxymaltose (FCM), commonly marketed under brand names like Injectafer or Ferinject, for the risk of serious hypophosphatemia. Learn what this change means for people with HHT, their caregivers, and the healthcare professionals who treat them.
Read MoreVisible Together: The Strength of Team Ella
Ella’s family was searching for answers to one set of questions when genetic testing revealed something they had never heard of before: HHT. Now, during HHT Awareness Month, they are sharing her story so other families can find answers sooner.
Read MoreVisible Together: Kelsey’s Story
For much of Kelsey’s life, HHT was there before it had a name. It was present in her family history, in her father’s severe nosebleeds, and later in complications no one could see from the outside. Diagnosed at age 11, Kelsey would eventually face pulmonary arterial hypertension, chronic anemia, and a double lung transplant. Her story is a powerful reminder that HHT is not “just nosebleeds”—and that visibility, education, and specialized care can change everything.
Read MoreVisible Together: Three Generations of HHT
For Erin Yorke, hereditary hemorrhagic telangiectasia (HHT) is not just her diagnosis. It is her son’s future, her mother’s daily reality, and the reason visibility can change everything.
Read MoreVisible Together: Jenn’s Birthday Wish
Jenn shares her birthday with Global HHT Awareness Day. After her son Barrett’s brain AVM led to a life-changing HHT diagnosis for her family, June 23 became more than a birthday—it became a wish for earlier diagnosis, better treatments, and a future where no family has to face HHT alone.
Read More